Johnson & Johnson vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared

Comparing Revenue Growth: J&J vs Walgreens (2014-2023)

__timestampJohnson & JohnsonWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20147433100000076392000000
Thursday, January 1, 201570074000000103444000000
Friday, January 1, 201671890000000117351000000
Sunday, January 1, 201776450000000118214000000
Monday, January 1, 201881581000000131537000000
Tuesday, January 1, 201982059000000120074000000
Wednesday, January 1, 202082584000000121982000000
Friday, January 1, 202178740000000132509000000
Saturday, January 1, 202279990000000132703000000
Sunday, January 1, 202385159000000139081000000
Monday, January 1, 202461350000000147658000000
Loading chart...

Infusing magic into the data realm

A Tale of Two Giants: Johnson & Johnson vs Walgreens Boots Alliance

In the ever-evolving landscape of the healthcare and retail sectors, Johnson & Johnson and Walgreens Boots Alliance stand as titans. From 2014 to 2023, these companies have showcased remarkable revenue trajectories. Johnson & Johnson, a stalwart in pharmaceuticals and consumer health, saw its revenue grow by approximately 15% over this period, peaking in 2023. Meanwhile, Walgreens Boots Alliance, a leader in retail pharmacy, experienced a robust 82% increase, reflecting its strategic expansions and acquisitions.

Revenue Growth Insights

While Johnson & Johnson's revenue remained relatively stable, Walgreens Boots Alliance's revenue surged, particularly between 2014 and 2024, despite missing data for 2024. This growth underscores Walgreens' aggressive market strategies and adaptability in a competitive environment. As these companies continue to innovate, their financial performances offer valuable insights into the dynamics of the healthcare and retail sectors.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025